Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effect of High Dose Atorvastatin (80 mg/d) Comparing With Placebo in Preventing Contrast-induced Nephropathy in Patients Undergoing Computed Tomography Coronary Angiography

NCT02114346 is registered in ClinicalTrials.gov with Isfahan University of Medical Sciences as lead sponsor.

NCT NCT02114346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02114346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effect of High Dose Atorvastatin (80 mg/d) Comparing With Placebo in Preventing Contrast-induced Nephropathy in Patients Undergoing Computed Tomography Coronary Angiography
Lead sponsor
Isfahan University of Medical Sciences
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2013
Completion date
February 28, 2014
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-induced nephropathy